Borgavix 75 mg 30 tablets

Borgavix 75 mg 30 tablets

Composition: 

Each film-coated tablet contains Clopidogrel 75 mg.

Product Description: 

Borgavix is an antiplatelet aggregation agent.
It is used to reduce the risk of blood clots by inhibiting platelet aggregation.

Indications for Use: 

Prevention of atherothrombotic events in patients with recent myocardial infarction, ischemic stroke, or established peripheral arterial disease.
Often prescribed after stent placement or in combination with aspirin for acute coronary syndrome.

Method of Administration and Dosage: 

Adults: one 75 mg tablet daily, swallowed whole with water.
Dosage may vary depending on physician’s instructions.

Contraindications: 

Hypersensitivity to clopidogrel or excipients.
Contraindicated in active pathological bleeding (e.g., peptic ulcer, intracranial hemorrhage).

Precautions: 

Use with caution in patients at risk of bleeding, with liver impairment, or undergoing surgery.
Monitor for signs of bleeding.

Adverse Reactions (Side Effects): 

Possible bleeding, bruising, gastrointestinal discomfort, rash, or diarrhea.
Rare cases of severe bleeding or thrombotic thrombocytopenic purpura (TTP).

Pregnancy and Lactation: 

Use only if clearly needed and prescribed by a physician;
Safety data are limited.

Storage Conditions: 

Store below 25°C, in a dry place, protected from light and moisture.

Packaging: 

Box of 30 film-coated tablets.